OneMedNet Corp (ONMD) - Form 8-K Summary
Business Context and Reporting Period
OneMedNet Corporation, a Delaware corporation, filed this Current Report on Form 8-K on June 20, 2024. The Company is listed on The Nasdaq Capital Market under the symbols ONMD (Common Stock) and ONMDW (Redeemable Warrants). The filing addresses a regulatory compliance issue regarding the timely submission of periodic financial reports.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the status of the Company's listing compliance rather than financial performance data.
Material Changes and Events
- Delinquency Notification: On June 20, 2024, the Company received a notice from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to the failure to timely file its Form 10-Q for the fiscal quarter ended March 31, 2024.
- Trading Status: The notice does not have an immediate effect on the listing or trading of the Company's securities; trading continues under the symbol ONMD.
Outlook, Risks, and Management Commentary
- Compliance Plan: The Company has 60 calendar days to submit a plan to regain compliance. If accepted, Nasdaq may grant up to 180 calendar days (until December 11, 2024) to file the delinquent report.
- Uncertainty: Management states there can be no assurance that the plan will be accepted or that compliance will be regained within the specified timeframe.
- Management Action: The Company is working diligently to complete the Form 10-Q and intends to file it as promptly as possible. A press release detailing the plan was issued on June 24, 2024.
Investor Verification Checklist
- Verify the filing status of the Form 10-Q for the quarter ended March 31, 2024, on the SEC EDGAR database.
- Monitor the Company's submission of a compliance plan to Nasdaq within the 60-day window.
- Review the attached press release (Exhibit 99.1) for specific details on the remediation plan.
- Check for any subsequent 8-K filings regarding the acceptance or rejection of the compliance plan by Nasdaq.